Clinical Trial Data Analytics Witnesses Widespread Adoption Amidst the Coronavirus Pandemic: Quantzig’s Healthcare Data Analytics Experts Share Their Thoughts

March 19, 2020 Off By BusinessWire

LONDON–(BUSINESS WIRE)–#Analytics–Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems analyzes the reasons behind the growing adoption of clinical trial data analytics.

What might be holding the life science industry back from achieving better drug development proficiency? Speak to an expert to find out.

Searching for disease cures is an inherently complex, costly and time-consuming business fraught with risk. For those who are starting out, it’s crucial to note that the healthcare and life sciences industry as a whole is fraught with challenges and has a tendency to be risk-averse and siloed. With leading players in this sector not paying heed to the template being used for clinical trials, they are witnessing a slow growth curve and inefficient outcomes. And to add to their woes, the regulatory environment is getting stricter with new, advanced technologies paving their way into mainstream business operations. The additional pressures on the healthcare and life sciences industry are now promoting businesses to seek innovative paths to drive profits & clinical trial outcomes.

Schedule a FREE demo with our healthcare provider analytics experts to learn how clinical data analytics can help you combine data-driven insights in a meaningful way to enhance clinical trial outcomes.

According to our experts, the huge amounts of clinical trial data captured in clinical trials typically gets used only once. The data is rarely ever leveraged again and certainly not by the industry as a whole. This represents a huge amount of wasted potential because succeeding trials of the same phase or therapeutic area could benefit from the insights and performance benchmarks obtained from the clinical trial data. All this data, held confidential and anonymous, can be aggregated over time from tens of thousands of trials without compromising the proprietary integrity of the organization. Also, the operational insights from such data can be of tremendous benefit to anyone thinking of conducting a clinical trial in the future. Quantzig, through its advanced portfolio of clinical trial data analytics solutions, aims to help businesses leverage data analytics in clinical trials to overcome such challenges and improve outcomes.

Quantzig’s comprehensive suite of Clinical Trial Data Analytics solutions provides an edge by empowering lifesciences and pharma companies with insights to:

  1. Enhance Trial Visibility

    Collaborating with Quantzig can help you seamlessly integrate all your clinical trial data to achieve clarity across your clinical trials and improve time-to-market. Request a FREE proof of concept to learn more about our clinical trial data analytics capabilities.

  2. Quickly Identify and Mitigate Risk

    Leveraging data analytics in clinical trials can help you gain real-time access to trial performance, proactively mitigate risks, and move ahead with confidence. Gain limited-time complimentary access to our analytics platform to explore the benefits of our solutions.

  3. Foster Unrivaled Collaboration

    Adopt a holistic approach that helps drive collaboration among CRO, analysts, vendors, and stakeholders.

Our experience in working with the world’s leading drug manufacturers and healthcare organizations has helped us develop a comprehensive suite of clinical trial data analytics solutions to improve drug development, clinical trial accuracy, and healthcare data management. Stay ahead of the curve by leveraging clinical trial data analytics to explore new opportunities and drive improvements, Request a FREE proposal for personalized recommendations and solution insights.

About Quantzig

Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit:


Anirban Choudhury

Marketing Manager

US: +1 630 538 7144

UK: +44 208 629 1455